See More Hear More Watch More Hear More Get on iTunes
Marketplace marketplace

Valeant: How Aggressively Can A Drug Company Sell

After seeing its stock price soar, Valeant Pharmaceuticals of Canada is now under pressure and its shares are down more than 60 percent. Several hedge funds that are principal investors in the high-flying, high-profit company, are fiercely defending it against allegations of improper business and accounting practices. more info: #FullNewsAudioAvailable


More from